Maddy summary# Summary of Proposed Legislation This document outlines a comprehensive U.S. legislative proposal with several key components: 1. **Research Restrictions**: - Requires certification from Federal research grant recipients that they are not Chinese citizens or participants in Chinese talent programs - Prohibits employment of Chinese nationals in federally funded research - Requires institutions receiving Federal assistance to agree not to knowingly employ individuals participating in Chinese talent programs 2. **Foreign Gifts and Contracts Disclosure**: - Mandates disclosure of foreign gifts/contracts over $50,000 to universities - Requires public reporting of restricted/conditional gifts/contracts - Creates a searchable public database of foreign gifts to universities - Requires institutions to maintain policies regarding foreign gifts to faculty and staff 3. **Investment Restrictions**: - Restricts tax-exempt organizations from holding investments in "disqualified Chinese companies" (defined as corporations incorporated in China or with significant Chinese government ownership) - Requires annual reporting on such investments - Allows limited waivers with public disclosure 4. **Taiwan Policy**: - Prohibits U.S. government from recognizing PRC claims to sovereignty over Taiwan without Taiwan's consent - Requires U.S. government to treat Taiwan's democratically elected government as the legitimate representative of the people of Taiwan - Requires a strategy to protect U.S. businesses from Chinese coercion efforts 5. **Additional Provisions**: - Requires participants in Chinese talent programs to register as agents of the Chinese government - Amends economic espionage laws to include education and research - Mandates disclosure of certain funds received by visa holders The legislation represents a significant effort to limit Chinese influence in U.S. academic institutions, research, and business sectors while establishing a more robust policy framework regarding Taiwan.
Sponsored bills
Maddy summaryHR 6817 imposes a 10% fee on money sent overseas through remittance services (e.g., Western Union, MoneyGram) to fund border security. The fee applies to all international transfers, with U.S. citizens receiving a refundable tax credit equal to the fee paid. Collected fees will fund the new Border Enforcement Trust Fund, which can only be used to hire border agents, build barriers along the U.S.-Mexico border, and operate detention facilities for undocumented immigrants. The bill also includes penalties for evading the fee and restricts foreign aid for countries aiding fee evasion.
Maddy summaryThe Maximum Pressure Act (HR 6114) is a legislative proposal that would maintain and expand U.S. sanctions against Iran. The bill would codify existing sanctions, require Iran to meet 12 specific conditions before sanctions could be lifted (including ending support for terrorism, releasing hostages, and ending nuclear enrichment), and expand sanctions on Iran's Revolutionary Guard Corps and missile programs. It also establishes new reporting requirements for the U.S. government to monitor Iran's activities and the impact of sanctions. The legislation would require congressional review before any sanctions could be lifted or modified, preventing the executive branch from unilaterally easing restrictions.
Maddy summaryHR 5737, the Elevating HSA Limits Act of 2023, increases the maximum annual contribution limits for Health Savings Accounts (HSAs) to match the deductible and out-of-pocket limits of qualifying high-deductible health insurance plans. This change directly affects individuals with HDHPs who use HSAs, as their annual contribution caps will now automatically adjust each year based on the current plan's deductible and out-of-pocket maximums instead of fixed 2023 dollar amounts. The bill amends the Internal Revenue Code to replace the current fixed limits ($2,250 for self-only coverage and $4,500 for family coverage) with a dynamic formula tied to plan costs. These changes apply to tax years beginning after December 31, 2023.
Maddy summaryThis bill amends tax code rules to allow married individuals to contribute to their own health flexible spending account (FSA) even if their spouse already has an FSA. It permits these contributions provided the combined reimbursements for both spouses do not exceed the total eligible expenses that would apply if the spouse's account didn't exist. The change applies to health savings plans starting in 2024, affecting married taxpayers with dual FSA coverage. It clarifies the reimbursement limits without creating new benefits or altering existing FSA structures.
Maddy summaryThe ORPHAN Cures Act amends the Drug Price Negotiation Program under the Social Security Act to clarify how orphan drugs (medications for rare diseases affecting fewer than 200,000 people in the U.S.) are treated. It ensures that periods when a drug was designated as an orphan drug are excluded from the time calculation used to determine when the drug can no longer be excluded from price negotiations. The bill also updates the definition to allow a single drug to be designated for multiple rare diseases, rather than just one. This change provides clearer rules for manufacturers and the government regarding orphan drug exclusions in the program.
Maddy summaryThe Maintaining Investments in New Innovation Act (HR 5547) extends the exclusivity period for certain advanced drugs from 7 to 11 years. It defines an "advanced drug product" as a drug using genetically targeted technology to change how genes work, such as drugs that suppress or activate gene function. The bill amends the Social Security Act to update the definition of "qualifying single source drug" to include these advanced therapies with the longer exclusivity period. This change directly affects drug manufacturers developing such advanced therapies and influences Medicare's drug coverage rules by delaying generic competition for these specific treatments.
Maddy summaryThis bill clarifies that Medicare must cover external infusion pumps and associated non-self-administrable drugs as durable medical equipment (DME) when specific criteria are met. It directly affects Medicare beneficiaries requiring home infusion therapy for drugs that must be prepared just before use, administered by a healthcare professional, or labeled for external pump use at least monthly. Key provisions require the drug's FDA labeling to specify external pump administration, safe home delivery by qualified suppliers, and preparation/administration requirements. The bill mandates Medicare coverage under existing rules (LCD L33794) for qualifying treatments, effective upon enactment or FDA approval, whichever is later.
Maddy summaryThis bill allows employees to directly transfer funds from a health flexible spending account (FSA) or health reimbursement arrangement (HRA) to a health savings account (HSA) when switching to a high-deductible health plan after a gap in coverage. It sets a dollar limit on these transfers based on annual HSA contribution rules and requires the transfer to occur after a significant period without coverage. Employers must report these transfers on employees' W-2 forms. The changes apply to distributions made after December 31, 2023.
Maddy summaryThis bill amends the Affordable Care Act and Medicaid/CHIP programs to deny health insurance subsidies, coverage, and related benefits to individuals with Deferred Action for Childhood Arrivals (DACA) status. Specifically, it excludes people lawfully present only due to the 2012 DHS memo granting deferred action from eligibility for ACA subsidies, Medicaid, and the State Children's Health Insurance Program (CHIP). The bill requires states to remove DACA recipients from enrollment in health plans and rescind any existing waivers that allowed such coverage. It directly affects approximately 800,000 DACA recipients who currently qualify for ACA subsidies and Medicaid/CHIP under existing rules.